Wang Lai 4

What Happened

• Wang Lai, President and Global Head of R&D of BeOne Medicines (ONC), disposed of 1,169 American Depositary Shares (ADS) on 2026-06-16. The weighted-average price was $265.39 per ADS, for total proceeds of $310,236. The shares were sold in multiple transactions at prices ranging from $265.385 to $265.775.
• This was a sale (not a purchase) effected to satisfy a mandatory tax withholding obligation in connection with the vesting of restricted share units (RSUs), not an independent open-market investment decision.

Key Details

• Transaction date: 2026-06-16; Form 4 filed: 2026-06-18 (appears timely within the two-business-day requirement).
• Reported sale: 1,169 ADS; weighted-average price $265.39; price range $265.385–$265.775; proceeds $310,236.
• Reason/code: Tax withholding on RSU vesting (footnote F6 / transaction code F).
• Vesting detail: RSUs vest 1/4th on each anniversary of June 15, 2023, subject to continued service; unvested shares may accelerate on certain terminations (F6).
• ADS conversion: 1 ADS represents 13 ordinary shares (F5).
• Shares owned after transaction: Not disclosed in this filing.
• Other footnotes of note: Securities held partly through Wang Holdings LLC (reporting person disclaims beneficial ownership) (F1). The filing also references participation in a PRC RMB Shares Employee Participation Plan and related disclaimers of beneficial ownership/pecuniary interest (F2–F4).

Context

• Sales to cover tax withholding on vesting are common and generally considered routine; they do not necessarily signal the insider’s view of the company’s prospects.
• For broader insider activity, compare this transaction with other recent insider filings (purchases are typically more indicative of bullish sentiment).